Drug delivery and advanced therapies: navigating the complexities of drug delivery device development

Many new targeted therapies, such as biologics, require complex cold chain logistics due to their instability at room temperature – sometimes even needing -80°C storage. In this video, TTP’s Device Innovation Lead, Matt Parker and Head of Respiratory, Svilen Savov discuss promising reconstitution solutions to simplify the process for patients, particularly in at-home settings. With a focus on automation, ease of use and adaptability, innovation in device development is essential for improving therapy administration, reducing environmental impact, and making these treatments more accessible and sustainable.